Haisco Pharmaceutical Group

Performance

About Haisco Pharmaceutical Group

Haisco Pharmaceutical Group Co., Ltd., established in 2000 and listed on the Shenzhen Stock Exchange, is a leading Chinese pharmaceutical group focused on innovative drug research and strong sales capabilities. The company is a leader in the parenteral nutrition industry and holds a significant market position in liver disease medications. With over 1,900 employees and a 450-strong R&D team including numerous PhDs and Masters, Haisco ranks among the top pharmaceutical firms in China by market value and innovation achievements. Since 2015, it has also expanded into the high-end medical device market.